Abstract:Besides the pathological hallmarks of β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs), increasing evidence suggests that neuroinflammation plays a significant role in AD pathogenesis. The complement pathway is a key regulator of innate immunity. Recent findings from our laboratory showed that the central complement component C3 is upregulated in astrocytes of AD patients and mouse models. Moreover, elevated astroglial C3 can modulate Aβ dynamics and pathology and reduce dendritic morphology and synaptic function through microglial and neuronal C3a receptor (C3aR), respectively. Giving the importance of the C3-C3aR axis in the CNS, we are interested in understanding whether the complement pathway also impacts the NFT pathology. We analyzed the expression patterns of complement pathway genes in AD, MCI and non-cognitive impaired brain samples obtained from the Religious Orders Study (ROS) and Rush Memory and Aging Project (MAP) cohorts and in the PS19 mouse model of tauopathy before or after the onset of NFT pathology. Next, we studied the functional effects of the C3-C3aR pathway on reactive gliosis and NFT pathology by genetically deleting C3aR or overexpressing neuronal C3aR in PS19 animals. Finally, we utilized RNA sequencing and reverse-phase proteomics (RPPA) to identify C3aR downstream signaling pathways that promote such effects. Analysis of RNA sequencing datasets from human brains revealed a strong upregulation of complement pathway genes that is highly correlated with Braak staging and cognitive decline. Prominent complement upregulation was also observed in PS19 mice in response to NFT pathology. AAV-driven neuronal overexpression of C3aR exacerbates tau/NFT pathology in PS19 animals. Conversely, knocking out C3aR in PS19 mice results in significant reduction of inflammation, phospho-tau levels and associated pathology and improved behavioral deficits of PS19 animals. Mechanistically, we identify the Jak-Stat3 pathway as a potent regulator of reactive gliosis and tau pathology in PS19 mice downstream of C3aR.

Complement System and Pathogenesis of Alzheimer's Disease

NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease.

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

The Importance of Complement-Mediated Immune Signaling in Alzheimer's Disease Pathogenesis

[O1–14–03]: THE ROLE OF COMPLEMENT C3 AND C3AR RECEPTOR IN TAU PATHOLOGY IN ALZHEIMER's DISEASE

Analysis of Complement System and Its Related Factors in Alzheimer’s Disease

THE ROLE OF COMPLEMENT C3 AND C3AR RECEPTOR IN TAU PATHOLOGY IN ALZHEIMER’S DISEASE

Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer's disease

Complement Protein C5a Enhances the Β-Amyloid-induced Neuro-Inflammatory Response in Microglia in Alzheimer’s Disease

Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease

C1q–calreticulin Induced Oxidative Neurotoxicity: Relevance for the Neuropathogenesis of Alzheimer's Disease

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia

The complement system in neurodegenerative and inflammatory diseases of the central nervous system

The Complement System, Aging, and Aging-Related Diseases

TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease

Complement in Neurologic Disease

Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer's Disease

Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease

Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1/NOX2 Pathway